Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy
- PMID: 15793168
- PMCID: PMC1068653
- DOI: 10.1128/AAC.49.4.1664-1665.2005
Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy
Erratum in
- Antimicrob Agents Chemother. 2005 May;49(5):2152
References
-
- Arbeit, R. D., D. Maki, F. P. Tally, E. Campanaro, and B. I. Eisenstein. 2004. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin. Infect. Dis. 38:1673-1681. - PubMed
-
- Cha, R., and M. Rybak. 2003. Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Diagn. Microbiol. Infect. Dis. 47:539-546. - PubMed
-
- Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Supplement M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa.
-
- NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. NCCLS, Wayne, Pa.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
